Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 17;11(9):1058.
doi: 10.3390/pathogens11091058.

SARS-CoV-2 Variants Identification: Overview of Molecular Existing Methods

Affiliations
Review

SARS-CoV-2 Variants Identification: Overview of Molecular Existing Methods

Giulia Berno et al. Pathogens. .

Abstract

Since the beginning of COVID-19 pandemic the Real Time sharing of genome sequences of circulating virus supported the diagnostics and surveillance of SARS-CoV-2 and its transmission dynamics. SARS-CoV-2 straightaway showed its tendency to mutate and adapt to the host, culminating in the emergence of variants; so it immediately became of crucial importance to be able to detect them quickly but also to be able to monitor in depth the changes on the whole genome to early identify the new possibly emerging variants. In this scenario, this manuscript aims to provide an overview of the existing methods for the identification of SARS-CoV-2 variants (from rapid method based on identification of one or more specific mutations to Whole Genome sequencing approach-WGS), taking into account limitations, advantages and applications of them in the field of diagnosis and surveillance of SARS-CoV-2.

Keywords: COVID-19; SARS-CoV-2; SARS-CoV-2 pandemic; rapid methods; sequencing; surveillance; variants characterization.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare that are relevant to the content of this article.

Figures

Figure 1
Figure 1
Non-synonymous mutations of SARS-CoV-2 variants. Mutation frequencies and nucleotide positions are reported together with corresponding gene locations. Graphic representation of Spike gene principal domains is also represented.
Figure 2
Figure 2
Pipeline of sample analysis in epidemiological surveillance. The sample of different individuals are analysed with RT-PCR or Rapid Test. Only the sample positive to RT- PCR with adequate viral load (Ct < 33) are further analysed with Sanger, NGS or Real Time RT-PCR. The variant identified results are then send to the surveillance authority.

References

    1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017. - DOI - PMC - PubMed
    1. World Health Organization (WHO) WHO Coronavirus (COVID-19) Dashboard. [(accessed on 26 August 2022)]. Available online: https://covid19.who.int/
    1. Wu F., Zhao S., Yu B., Chen Y.M., Wang W., Song Z.G., Hu Y., Tao Z., Tian J., Pei Y., et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265–269. doi: 10.1038/s41586-020-2008-3. - DOI - PMC - PubMed
    1. Oude Munnink B.B., Worp N., Nieuwenhuijse D.F., Sikkema R.S., Haagmans B., Fouchier R.A.M., Koopmans M. The next phase of SARS-CoV-2 surveillance: Real-time molecular epidemiology. Nat. Med. 2021;27:1518–1524. doi: 10.1038/s41591-021-01472-w. - DOI - PubMed
    1. Mohammadi E., Shafiee F., Shahzamani K., Ranjbar M.M., Alibakhshi A., Ahangarzadeh S., Beikmohammadi L., Shariati L., Hooshmandi S., Ataei B., et al. Novel and emerging mutations of SARS-CoV-2: Biomedical implications. Biomed. Pharmacother. 2021;139:111599. doi: 10.1016/j.biopha.2021.111599. Erratum in Biomed. Pharmacother. 2021, 140, 111723. - DOI - PMC - PubMed

LinkOut - more resources